How Molecular Structure Influences Potency Of A Therapeutic Biologic

Monoclonal antibodies are a rapidly expanding sector. These drugs are complex in their structure and their mode of actions. This webinar takes a closer look at one of these drugs: Humira® (Adalimumab). The focus of this presentation is glycans. We will look at how to choose an analytical method and how changes to these glycan molecules affect the biological activity of the drugs. In this webinar, MilliporeSigma scientists, ranging in specialty from analytical to immuno-focused, give the listener an understanding of how an antibody’s molecular structure, of which there are many measurable properties that can be measured, influences its binding and affects potency of a therapeutic biologic.